Targeted Degradation of SOS1 Exhibits Potent Anticancer Activity and Overcomes Resistance in KRAS-Mutant Tumors and BCR-ABL-Positive Leukemia.
Luo Z, Lin C, Yu C, Yuan C, Wu W, Xu X, Sun R, Jia Y, Wang Y, Shen J, Wang D, Wang S, Jiang H, Jiang B, Yang X, Xie C.
Luo Z, et al. Among authors: jiang b, jiang h.
Cancer Res. 2025 Jan 2;85(1):101-117. doi: 10.1158/0008-5472.CAN-24-1093.
Cancer Res. 2025.
PMID: 39437162
Free PMC article.